The Journal of Immunology, Vol 149, Issue 7 2406-2414, Copyright © 1992 by American Association of Immunologists

ARTICLES

Cytotoxic T lymphocytes show HLA-C-restricted recognition of EBV- bearing cells and allorecognition of HLA class I molecules presenting self-peptides

DJ Schendel, C Reinhardt, PJ Nelson, B Maget, L Pullen, GW Bornkamm and A Steinle
Institut fur Immunologie, Ludwig-Maximilians Universitat, Munchen, Germany.

Human CTL have been isolated that show self-restricted recognition of autologous lymphoblastoid cell lines and allorecognition. The lymphoblastoid cell line ligand most likely used a peptide that is expressed in EBV-bearing cells when the virus enters the lytic cycle. This peptide is presented to CD8+ CTL by HLA-Cw7 molecules. The allogeneic ligand recognized on non-EBV-infected cells is composed of a class I glycoprotein and a naturally selected self-peptide. In previous studies we demonstrated that this ligand is determined by two MHC- linked genes: one gene encodes the allogeneic class I molecule whereas the other controls the self-peptide. Despite the use of different peptides and different class I molecules, seemingly equivalent structures are formed that enable these two ligands to function as antigenic mimics of each other. CTL with the same patterns of dual specificity could be isolated from four unrelated donors, indicating that HLA-Cw7 is frequently involved in self-restricted recognition of EBV-harboring cells. Such CTL could help not only to contain lytic virus during a primary infection but also may be maintained life-long to eliminate cells in which reactivated virus appears.

This article has been cited by other articles:

				Z. Zhang, L. Kaptanoglu, W. Haddad, D. Ivancic, Z. Alnadjim, S. Hurst, D. Tishler, A. D. Luster, T. A. Barrett, and J. Fryer Donor T Cell Activation Initiates Small Bowel Allograft Rejection Through an IFN-{gamma}-Inducible Protein-10-Dependent Mechanism J. Immunol., April 1, 2002; 168(7): 3205 - 3212. [Abstract] [Full Text] [PDF]

				V. P. Khatri, R. A. Baiocchi, R. Peng, A. R. Oberkircher, J. M. Dolce, P. M. Ward, G. P. Herzig, and M. A. Caligiuri Endogenous CD8+ T Cell Expansion During Regression of Monoclonal EBV-Associated Posttransplant Lymphoproliferative Disorder J. Immunol., July 1, 1999; 163(1): 500 - 506. [Abstract] [Full Text] [PDF]

				M. Bar-Ner, A. Thibault, M. Tsokos, I. T. Magrath, and D. Samid Phenylbutyrate Induces Cell Differentiation and Modulates Epstein-Barr Virus Gene Expression in Burkitt's Lymphoma Cells Clin. Cancer Res., June 1, 1999; 5(6): 1509 - 1516. [Abstract] [Full Text] [PDF]

				S. Pepperl, G. Benninger-Doring, S. Modrow, H. Wolf, and W. Jilg Immediate-Early Transactivator Rta of Epstein-Barr Virus (EBV) Shows Multiple Epitopes Recognized by EBV-Specific Cytotoxic T Lymphocytes J. Virol., November 1, 1998; 72(11): 8644 - 8649. [Abstract] [Full Text] [PDF]

				P. Zheng and Y. Liu Costimulation by B7 Modulates Specificity of Cytotoxic T Lymphocytes: A Missing Link That Explains Some Bystander T Cell Activation J. Exp. Med., November 17, 1997; 186(10): 1787 - 1791. [Abstract] [Full Text] [PDF]

				N.M. Steven, N.E. Annels, A. Kumar, A.M. Leese, M.G. Kurilla, and A.B. Rickinson Immediate Early and Early Lytic Cycle Proteins Are Frequent Targets of the Epstein-Barr Virus-induced Cytotoxic T Cell Response J. Exp. Med., May 5, 1997; 185(9): 1605 - 1618. [Abstract] [Full Text] [PDF]

				S. Ehl, J. Hombach, P. Aichele, H. Hengartner, and R. M. Zinkernagel Bystander Activation of Cytotoxic T Cells: Studies on the Mechanism and Evaluation of In Vivo Significance in a Transgenic Mouse Model J. Exp. Med., April 7, 1997; 185(7): 1241 - 1252. [Abstract] [Full Text] [PDF]